Japanese Pharmas Need To Get More Global
This article was originally published in PharmAsia News
Executive Summary
Japanese pharmaceutical companies need to have a more global reach if they intend to be major players in an increasingly international biotech and pharma market, according to Berkeley, Calif.-based Plexxikon CEO Peter Hirth